Assessing for the dysfunction of Lamp5 and related modulators of cortical inhibitory interneuronal function, with a view to unlocking the initial pathogenic event in ALS, may further inform pathophysiological insights into neurological disease and lead to development of novel therapeutic strategies. The gene discussed is LAMP5; the disease is amyotrophic lateral sclerosis.